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ABSTRACT 
Introduction:  Significant disparities in immediate breast reconstruction after mastectomy 
have persisted, and may even be increasing, despite large-scale efforts to minimize them, such as 
the Women’s Health and Cancer Rights Act of 1998. Immediate breast reconstruction has been 
shown to lead to higher rates of surgical satisfaction, minimize delay in post-operative cancer 
treatment, and improve the quality of life and overall well-being of mastectomy patients. However 
only 25-40% of eligible women in the United States receive reconstruction. The rate of 
reconstruction is even lower in African American and Hispanic women compared to White 
women. To better understand this disparity, this study uses national population-based data to 
examine how demographic factors, socioeconomic factors, and disease characteristics interact and 
affect the rate of immediate breast reconstruction (IBR) after mastectomy. 
Methods:  Women with AJCC7 Stage 0-III breast cancer who underwent mastectomy from 
2010 to 2012 were identified in the Surveillance, Epidemiology and End Results Program (SEER) 
database. Race, Hispanic ethnicity, age, marital status, insurance status, tumor grade, AJCC7 stage 
and hormone receptor/ Her2Neu profile were compared between women undergoing mastectomy 
with IBR and mastectomy alone using univariate and multivariate analysis. 
Results:  We identified 51,115 women who underwent mastectomy for Stage 0-III breast 
cancer from 2010-2012, of whom 15,389 (30.1%) received IBR. On multivariate analysis, age (p 
Conclusion:  The decision to undergo reconstruction after mastectomy is influenced by 
many factors. Our results show that even after adjusting for tumor characteristics, socioeconomic 
factors are independently associated with receiving IBR after mastectomy. Further research is 
needed to elucidate the factors that influence the decision to undergo IBR in order to eliminate 
these persistent disparities. 
Keywords:  breast; reconstruction; race 
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INTRODUCTION 
Breast cancer is the most common cancer in women in the United States, with 224,147 
cases diagnosed in women in 2012, and is the second leading cause of cancer deaths in women, 
with increasing incidence (Centers for Disease Control and Prevention, 2018, June 12). Black 
women have a worse prognosis than White women, often presenting at a later stage and with a 
shortened survival rate. Numerous investigators have explored this difference, which has been 
attributed to differences in screening, socioeconomic status, insurance status, treatment regimen 
and timing, comorbidities, and tumor biology (Byers et al., 2008; Carey et al., 2006; Chagpar, 
Crutcher, Cornwell, & McMasters, 2011; Clarke et al., 2012; Cross, Harris, & Recht, 2002; Curtis, 
Quale, Haggstrom, & Smith-Bindman, 2008; Dent et al., 2007; Gorey et al., 2009; Gorin, Heck, 
Cheng, & Smith, 2006; Grann et al., 2006; Haas et al., 2008; Hershman et al., 2005; McBride et 
al., 2007; McCarthy et al., 1998; Ooi, Martinez, & Li, 2011; Smith-Bindman et al., 2006; 
Tammemagi, Nerenz, Neslund-Dudas, Feldkamp, & Nathanson, 2005; Ward et al., 2004). 
There are three molecular markers currently used to classify breast cancer; Estrogen 
Receptors, Progesterone Receptors and Her2Neu receptors. Triple Negative Breast Cancer 
(TNBC) does not express any of these receptors, and has the most aggressive tumor biology. 
TNBC is associated with diagnosis at a younger age, high-tumor grade, larger mean tumor size at 
presentation, and higher rates of mortality compared to other tumor subtypes. The highest rate of 
TNBC occurs in young Black women (Clarke et al., 2012; Dent et al., 2007). 
Though breast-conserving therapy is more prevalent, mastectomy is a commonly 
performed procedure, accounting for 38% of resections for early-stage breast cancer (Mahmood 
et al., 2013). After mastectomy, immediate breast reconstruction (IBR) has been shown to improve 
surgical satisfaction, minimize pain, improve physical and sexual function while not delaying time 
to adjuvant treatment or increasing the risk of disease recurrence (Eltahir et al., 2013; Yang, 
Newman, Lin, et al., 2013). However, only thirty-seven percent of women in one large database 
study were noted to undergo IBR (Eltahir et al., 2013). This is the case despite efforts such as the 
Women’s Health and Cancer Rights Act of 1998, which mandates insurance coverage for 
reconstruction in women who undergo mastectomy. 
Further compounding the issue, Black women undergo IBR at a rate significantly lower 
than their White counterparts after mastectomy (Tseng et al., 2004; Yang, Newman, Reinke, et al., 
2013). The objective of this study was to use a national population-based data to examine how 
demographic factors, socioeconomic factors, and disease characteristics interact and affect the 
rate of IBR after mastectomy. 
 
METHODS 
Participants 
This study was granted exempt status approved by the Institutional Review Board. Women 
with American Joint Committee on Cancer (AJCC) 7 Stage 0 – III breast cancer who underwent 
surgical treatment for pathologically confirmed breast cancer were selected from all 18 registries 
of the Surveillance, Epidemiology, and End Results (SEER) database. Subjects were categorized 
as having undergone mastectomy alone or mastectomy with immediate breast reconstruction 
(IBR). The following patients were excluded: male patients, patients with stage IV disease, patients 
whose case was reported via death certificate or autopsy, and patients whose type of surgery was 
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unknown. Stage IV patients were excluded as surgical resection in not typically a first-line 
treatment for patients presenting at this disease stage.   
Design 
Both tumor specific and socioeconomic factors were analyzed. Patients were divided into 
four mutually exclusive subtypes based on their Her2-Neu and Hormone Receptor (HR) status. 
Patients who are Estrogen and/or Progesterone receptor positive were considered to be HR 
positive. Patients were also stratified based on their AJCC and pathologic grade (1-4). Women 
were split into age groups (<40, 40-49, 50-59, 60-69, 70-79 and >80) and further categorized by 
race (Caucasian, African-American and Other - American Indian/Alaska Native, Asian/Pacific 
Islander), Hispanic ethnicity, marital status (married, single, separated/divorced, and widowed), 
and insurance status (private insurance, uninsured, and Medicaid). 
Statistical Analysis 
A chi squared test for association was used to determine which variables were associated 
with IBR. A multivariate logistic regression analysis using all statistically significant variables was 
then performed to evaluate which variables were independently associated with IBR. Tumor 
subtype, AJCC7 stage, pathologic grade, race, Hispanic ethnicity, marital status and insurance type 
were included in the multivariate regression. Both tests were two-tailed and a p-value < 0.05 was 
considered statistically significant. The C-statistic was used to determine the model’s 
discriminative ability. The Hosmer-Lemeshow statistic was used to determine goodness of fit.  All 
analyses were conducted using SPSS version 24 ("IBM SPSS Statistics for Macintosh," 2016). 
 
RESULTS 
From 2010 – 2012, there were 51,115 patients who underwent mastectomy for breast 
cancer. The rate of IBR was 30.10% (n = 15,386).  
Univariate Analysis  
Univariate analysis (Table 1) revealed statistically significant difference in IBR rates 
associated with tumor subtype (2 (3) = 75.15, p <0.0001), age (2 (5) = 6116.67 p <0.0001)  
AJCC7 stage (2 (3) = 649.40, p <0.0001) pathologic grade (2 (3) = 36.21, p <0.0001), race (2 
(2) = 186.81 p <0.0001), Hispanic ethnicity (2 (1) = 68.70, p <0.0001), marital status ((2 (3) = 
1913.11, p <0.0001) and insurance type (2 (2) = 953.35, p <0.0001).  
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Table 1: Univariate analyses of factors associated with IBR  
 Sample Size  % of sample 
Reconstruction  
rate (%) 2 p value 
Subtype    75.15 <0.0001 
Her2 + / HR +  5988 11.70 32.2   
Her2 + / HR - 2947 5.8 28.6   
Her2 - / HR + 35584 69.6 30.7   
TNBC 6596 12.9 25.9   
Age    6116.67 <0.0001 
< 40 3696 7.2 49.8   
40-49 10425 20.4 48   
50-59 12812 25.1 37.5   
60-69 12009 23.5 24.8   
70-79 7722 15.1 9   
 > 80 4451 8.7 1.6   
Stage    649.40 <0.0001 
is 1046 2 42.3   
I 19846 38.8 34.9   
II 19975 39.1 29.1   
III 10248 20 21.6   
Grade    36.21 <0.0001 
1 9276 18.1 32.1   
2 22411 43.8 30.4   
3 19139 37.4 28.7   
4 289 0.6 30.4   
Marital Status    1913.11 <0.0001 
Married 30156 59 35.7   
Single  7804 15.3 28.5   
Separated / 
Divorced 6221 12.2 12.2   
Widowed 6934 13.6 13.6   
Race    186.81 <0.0001 
White 40607 79.4 31.5   
Black 5339 10.4 25.9   
Other 5169 10.1 23.6   
Hispanic    68.70 <0.0001 
No 45297 88.6 30.7   
Yes 5818 11.4 25.4   
Insurance Status     953.35 <0.0001 
Uninsured 1046 2 19.6   
Medicaid  7268 14.2 15.4   
Insured 42801 83.7 32.9   
 
Multivariate Analysis 
 A logistic regression model was created using the factors found to be associated with 
patients receiving IBR. In the multivariate logistic regression analysis, age (p<0.0001), marital 
status (p<0.0001), race (p<0.0001), Hispanic ethnicity (p<0.0001), grade (p = 0.0045), insurance 
status (p<0.0001), AJCC7 stage (p<0.0001), and ER/PR/Her2 receptor status (p<0.0001) were all 
independently associated with IBR. Patients more likely to undergo mastectomy with IBR were 
younger (age < 40: OR = 2.11; age 40 – 49: OR = 1.66) and presented at a less advanced stage 
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(stage is: OR = 1.87; stage I: OR = 1.37). Factors independently associated with not undergoing 
IBR were Black race (OR = 0.75), Hispanic ethnicity (OR = 0.62), being uninsured (OR = 0.39) 
or insured by Medicaid (OR = 0.36), tumor grade 3 (OR = 0.93), presenting at an advanced stage 
(stage III: OR 0.64), and having triple negative disease (OR = 0.79).   
 The C-statistic for this model was 0.768, demonstrating good discriminative ability. The 
Hosmer-Lemeshow statistic (p = 0.928) suggesting that the model does not over-fit the data. 
 
Table 2: Multivariate logistic regression of factors predicting IBR  
  OR 95% CI p value  
Subtype    
Her2 + / HR +  Ref   
Her2 + / HR - 0.94 .85 - 1.05 0.291 
Her2 - / HR + 1.05 .99 - 1.13 0.115 
TNBC 0.83 .77 - .91 <0.0001 
Age    
< 40 2.11 1.95 - 2.29 <0.0001 
40-49 1.66 1.57 - 1.75 <0.0001 
50-59 Ref   
60-69 0.50 .47 - .52 <0.0001 
70-79 0.14 .13 - .16 <0.0001 
> 80 0.03 .02 - .03 <0.0001 
Stage    
is 1.87 1.62 - 2.16 <0.0001 
I 1.37 1.30 - 1.44 <0.0001 
II Ref   
III 0.64 .60 - .68 <0.0001 
Grade    
1 Ref   
2 0.96 .91 - 1.02 0.203 
3 0.89 .83 - .95 0.001 
4 0.88 .66 - 1.18 0.397 
Marital Status   
Married Ref   
Single  0.82 .77 - .87   <0.0001 
Separated / 
Divorced 0.94 .88 - 1.00 0.056 
Widowed 0.67 .60 - .74 <0.0001 
Race    
White Ref   
Black 0.75 .70 - .81 <0.0001 
Other 0.49 .45 - .52 <0.0001 
Hispanic    
No Ref   
Yes 0.62 .58 - .66 <0.0001 
Insurance Status    
Uninsured 0.39 .34 - .46 <0.0001 
Medicaid  0.37 .34 - .39 <0.0001 
Insured Ref   
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DISCUSSION 
  Our analysis of immediate breast reconstruction after mastectomy demonstrates that there 
are significant disparities among women who undergo this procedure. This disparity was 
multifactorial, with race, ethnicity, insurance status, age, stage, grade, and tumor subtype all shown 
to be independently associated with rate of reconstruction on multivariate logistic regression. 
Though previous studies have these demographic variables to be significant, tumor subtype has 
not been extensively studied as a predictor of the likelihood of immediate reconstruction (Tseng 
et al., 2004; Yang, Newman, Reinke, et al., 2013).  
  In our study, Black women were significantly less likely to undergo immediate breast 
reconstruction than their White counterparts. Previous studies have associated inferior breast 
cancer care with socioeconomic status and lack of insurance (Gorey et al., 2009; Haas et al., 2008). 
However, even controlling for marital and insurance status in our multivariate logistic regression, 
Black women were less likely to undergo reconstruction. Additionally, we know of no other study 
which has investigated the hormone receptor status as an independent predictor of reconstruction. 
Perhaps armed with knowledge of aggressive tumor biology, physicians and patients are less apt 
to pursue immediate reconstruction.  
  A diagnosis of breast cancer, particularly one requiring mastectomy, is an anxiety-
provoking situation in which a woman faces both medical concerns of longevity as well as 
psychosocial concerns related to mastectomy. The benefits of immediate breast reconstruction are 
well-demonstrated. Eltahir et al. (2013) demonstrated that women who underwent IBR showed a 
significant improvement in satisfaction with their physical appearance. This cohort also had 
improved psychological and sexual outcomes, along with improved physical performance and had 
less pain and physical limitations than their counterparts who did not undergo reconstruction 
(Eltahir et al., 2013).  
  The Women’s Health and Cancer Rights Act of 1998 aimed to improve rates of 
reconstruction by requiring that health insurance companies pay for reconstruction after 
mastectomy. However, actual rates of reconstruction remain low. Our study demonstrates the 
complex, multifactorial nature of this issue. In a multivariate logistic regression analysis, we have 
demonstrated that even while controlling for age, race, socioeconomic status, and tumor stage 
women with triple-negative breast cancer are 17% less likely to get IBR than women with Her2 
positive, hormone receptor positive breast cancer. 
  Our study has several limitations. It is a retrospective database study, and thus is limited to 
the variables contained in that database. This may lead to biased estimates if other variables, which 
are not recorded in the SEER database, influence the likelihood a woman undergoes IBR. The 
molecular variation of breast cancer is far more complex than the four subtypes described by 
SEER, so we could potentially be over- or understating the effect of molecular markers on rates of 
reconstruction. Additionally, with such a large sample size, clinically insignificant differences can 
be seen as statistically significant.  
  This study also has a number of strengths. It is representative of nationwide cases of breast 
cancer, and thus highly generalizable to the United States population. The SEER database 
represents roughly 28% of cancer cases in the United States. Second, the large sample size of the 
study increased our statistical power and decreased the probability of committing a type 2 error. 
Third, we were able to control our statistical models for a number of confounders in a way that 
includes tumor biology subtypes. This is important as the knowledge of the molecular biology of 
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breast cancer continues to grow.  
In conclusion, we have demonstrated that several factors, including receptor status, 
influence the rate of immediate reconstruction post-mastectomy. Further research should aim to 
identify the particular reasons for this disparity. Rates of reconstruction following mastectomy 
could potentially be used as an indicator of the quality of care of an institution. This may serve to 
improve rates of reconstruction and eliminate the disparities that persist.  
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